NWBO - Northwest Biotherapeutics: Blinded By The Dazzle Of The Unblinding
- NWBO has run an 18-year long trial in GBM, one of the deadliest of cancers.
- It has been mired in controversies, and it has no cash.
- Its trial data has been locked, and will be blinded, hopefully in a short while.
For further details see:
Northwest Biotherapeutics: Blinded By The Dazzle Of The Unblinding